Volume 13, Number 8—August 2007
Research
Risk Factors for Colonization with Extended-Spectrum β-Lactamase–producing Bacteria and Intensive Care Unit Admission
Table 3
History of culture positivity with antimicrobial drug–resistant bacteria among 117 patients colonized with ESBL-producing bacteria at ICU admission*
Drug-resistant bacteria | No. ESBL colonized (%) |
---|---|
ESBL-positive clinical cultures before ICU admission† | 6 (5) |
ESBL-positive clinical cultures after colonization | 29 (25) |
Methicillin-resistant Staphylococcus aureus† | 25 (21) |
Vancomycin-resistant enterococci‡ | 27 (23) |
*ESBL, extended-spectrum β-lactamase; ICU, intensive care unit.
†Positive clinical cultures during the same hospital admission but before ICU admission.
‡Clinical or surveillance cultures at any time before ICU admission.